Daily SPAC Update – March 20, 2026

by | Mar 20, 2026

Another Quantum DeSPAC as DMY becomes Horizon Quantum. Inflection Point III Increases PIPE. UY Scuti Moves Vote Again. Blue Water IV IPOs for $125 Million.

SPAC IPO UPDATE

SPAC IPO Count

Monthly IPOs (last 13 months)
Latest: 7Prior: 27MoM: -20
3
Mar ’25
12
Apr ’25
22
May ’25
10
Jun ’25
13
Jul ’25
8
Aug ’25
14
Sep ’25
14
Oct ’25
10
Nov ’25
22
Dec ’25
24
Jan ’26
27Peak
Feb ’26
7
Mar ’26
Source: Boardroom Alpha
 

SPAC IPO:Blue Water Acquisition Corp. IV (BWIV)
Ticker: BWIV (Units: BWIVU)
Size: $125 Million
Sponsor: Blue Water Acquisition IV LLC (Blue Water Venture Partners)

Blue Water Acquisition Corp. IV priced its $125 million initial public offering on March 19, 2026, and begins trading on the NYSE today. This marks the fourth blank-check vehicle from Joseph Hernandez and the Blue Water Venture Partners team, following a consistent playbook of healthcare-centric deal-making. The sponsor has maintained a steady cadence in the space, notably taking Blue Water Vaccines public in 2022 and previously merging Blue Water Acquisition Corp. I with Clarus Therapeutics.

Strategy: The SPAC is zeroing in on high-potential targets within the biotechnology, healthcare, and technology sectors. Specific focus areas include drug discovery, medical devices, telemedicine, and the integration of AI and machine learning in pharmaceutical services. The management team intends to leverage its deep scientific and operational background to identify companies at the inflection point of commercialization.

Leadership Team:

  • Joseph Hernandez (Chairman & CEO): A serial entrepreneur and founder of Blue Water Venture Partners. He has a track record of scaling life sciences companies and led the previous three Blue Water SPAC iterations.
  • Jon Garfield (CFO): A veteran financial executive with extensive experience in the healthcare sector, having served in leadership roles across multiple Blue Water vehicles.

Structure: 12.5 million units at $10.00. Each unit consists of one Class A ordinary share and one-half (1/2) of one redeemable warrant. Each whole warrant entitles the holder to purchase one Class A ordinary share at $11.50. BTIG, LLC acted as the sole book-running manager for the offering.

 
New SPAC IPOs
DateTickerIssuerIPO Size
Mar 20BWIVBlue Water Acquisition Corp. IV$125M
Mar 19BHAVBHAV Acquisition Corp$100M
Mar 13PONOPONO CAPITAL FOUR INC$120M
Mar 12MTALMETALS ACQUISITION CORP II$200M  $30M overallotment
Mar 11SUMASUMA ACQUISITION CORP$150M  $23M overallotment
Source: Boardroom Alpha

DAILY SPAC UPDATE

SPAC VOTE RESULTS
ROSS – ROSS ACQUISITION CORP II * Extend to Sep 16, 2026 * 45,195 redeemed * $545,454 removed * trust $12.07

DeSPAC: Mar 20: DMYY DeSPAC to Horizon Quantum (HQ)
Horizon Quantum is developing a hardware-agnostic software platform that bridges the gaps between quantum hardware and applications. This platform makes quantum computing accessible to virtually any software developer, by removing the need for deep quantum expertise to develop applications and unleashing quantum’s potential. Horizon Quantum was founded by Dr. Joe Fitzsimons in 2018, a former professor with two decades of experience in quantum computing and computational complexity theory. Horizon Quantum’s leadership team also includes Dr. Si-Hui Tan, Chief Science Officer, who holds a Ph.D. in Physics from MIT and has been actively involved in quantum research for the same period.

OTHER SPAC NEWS
BACC – BLUE ACQUISITION CORP * Merger Agreement Amendment
IPCX – INFLECTION POINT ACQUISITION CORP III * PIPE Update
UYSC – UY SCUTI ACQUISITION CORP * Vote Adjourned

SEPARATE WARRANTS/RIGHTS
Mar 27: ARMADA ACQUISITION CORP III (AACI)
Mar 23: NEWBRIDGE ACQUISITION LTD (NBRG)
Mar 20: SPACE ASSET ACQUISITION CORP (SAAQ)
Mar 20: KRAKACQUISITION CORP (KRAQ)
Mar 19: GIGCAPITAL9 CORP (GIX)
Mar 19: MOUNTAIN LAKE ACQUISITION CORP II (MLAA)
Mar 18: XSOLLA SPAC 1 (XSLL)

SPAC DEAL TERMINATIONS (Last 10 Days)
2026-03-17: QSEA + Zhejiang Gaokai New Materials Co

SPAC MOVERS

YESTERDAY’S TOP SPAC GAINERS
CompanyTickerChangePriceStage
RISING DRAGON ACQUISITION CORPRDAC 6.1%$ 5.60Announced
ASPAC III ACQUISITION CORPASPC 0.8%$ 11.00Announced
DT CLOUD STAR ACQUISITION CORPDTSQ 0.8%$ 11.10Announced
CHURCHILL CAPITAL CORP XICCXI 0.6%$ 10.17Pre-Deal
M3-BRIGADE ACQUISITION V CORPMBAV 0.6%$ 10.72Announced
 
YESTERDAY’S TOP SPAC LOSERS
CompanyTickerChangePriceStage
CRANE HARBOR ACQUISITION CORPCHAC -8.2%$ 7.50Announced
VOYAGER ACQUISITION CORPVACH -7.0%$ 11.61Announced
AIMEI HEALTH TECHNOLOGY CO LTDAFJK -6.7%$ 26.30Announced
HORIZON SPACE ACQUISITION II CORPHSPT -4.2%$ 8.05Announced
TRAILBLAZER MERGER CORP ITBMC -2.6%$ 10.50Announced
Source: Boardroom Alpha market data

Recent Analysis

Daily SPAC Update – March 19, 2026

SPAC IPOs Slow as BHAV Acquisition’s IPO Makes it Only 6 for March. Integrated Wellness Extension and Voyager + Veraxa Biotech Deal Approved. Quartzsea Deal Terminated.

Daily SPAC Update – March 18, 2026

DMY Squared’s Quantum Deal Approved. Winvest Acquisition Extension Approved. Pelican Deal Vote Delayed. Alphatime Sets Extension Vote. Cayson Goes to Vote.

Daily SPAC Update – March 17, 2026

Harry You’s DMY Squared Deal Vote with Horizon Quantum Today. Pelican Acquisition Deal Vote. Abra and GNQ Insilico Deals Announced. Merlin DeSPAC.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.